SCHEMBL17436348

SCHEMBL17436348

Fc1ccc(-c2cnc(Cl)nc2)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 7/20 0.46
ALOX5AP P20292 5/20 0.46
KCNQ3 O43525 2/20 0.41
KCNQ2 O43526 2/20 0.41
KCNQ5 Q9NR82 2/20 0.41
CLK1 P49759 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
DHFR P00374 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
LMNA P02545 1/20 0.40
TTR P02766 1/20 0.40
ALB P02768 1/20 0.40
HMGB1 P09429 1/20 0.40
HPGD P15428 1/20 0.40
CXCL12 P48061 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17436330 0.79 CLK1 (0.47) FEN1ALOX5APCLK1
SCHEMBL14785263 0.78 HTR5A (0.39) ALDH1A1GRM5KMOGABRG2GABRB3
SCHEMBL30776664 0.78 FEN1 (0.47) FEN1ALOX5APHIF1AGRM5
SCHEMBL17436090 0.78 FEN1 (0.47) FEN1ALOX5APHIF1AGRM5
SCHEMBL30919844 0.77 HTR5A (0.43) CNR1KMOGABRG2GABRB3GABRA5
SCHEMBL16150623 0.76 ADORA2A (0.41) KDM4EMEN1USP2ALDH1A1DHFR
SCHEMBL27997963 0.76 GRIN2B (0.40) FEN1ALOX5APKCNQ3KCNQ2KCNQ5
SCHEMBL30224316 0.76 KMO (0.42) FEN1ALOX5APKDM4EMEN1USP2
SCHEMBL3273312 0.76 KMO (0.42) FEN1ALOX5APKDM4EMEN1USP2
SCHEMBL27095191 0.75 KMO (0.36) FEN1ALOX5APKCNQ3KCNQ2KCNQ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107074812-B Substituted pyrimidine compounds 格吕伦塔尔有限公司 2020-08-21 CN disclosed
EP-3527561-A1 NOVEL SUBSTITUTED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2019-08-21 EP disclosed
US-10189854-B2 Substituted pyrimidine compounds GRUENENTHAL GMBH (DE) 2019-01-29 US disclosed
EP-3169681-A1 NOVEL SUBSTITUTED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2017-05-24 EP disclosed
US-20170066776-A1 Novel substituted pyrimidine compounds GRUENENTHAL GMBH (DE) 2017-03-09 US disclosed
US-9540349-B2 Substituted pyrimidine compounds GRUENENTHAL GMBH (DE) 2017-01-10 US disclosed
US-20160016937-A1 Novel substituted pyrimidine compounds GRUENENTHAL GMBH (DE) 2016-01-21 US disclosed
WO-2016008593-A1 NOVEL SUBSTITUTED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2016-01-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10189854-B2 Substituted pyrimidine compounds TYMP, PDE4A, DPYD FEN1 179/4885ALOX5AP 1625/4885KCNQ3 3298/4885
US-20160016937-A1 Novel substituted pyrimidine compounds PDE4A, PDE4B, TYMP FEN1 213/4885ALOX5AP 1751/4885KCNQ3 3336/4885
US-20170066776-A1 Novel substituted pyrimidine compounds PDE4A, PDE4B, TYMP FEN1 213/4885ALOX5AP 1751/4885KCNQ3 3336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.